eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Meeting; Request for Comments
Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Meeting; Request for Comments
Document ID:
FDA-2012-N-0780-0001
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2012-19748
CFR Citation:
21 CFR Chapter I
View Document:
Details Information
Document Subtype:
Notice of Meeting
Received Date:
August 14 2012, at 12:00 AM Eastern Daylight Time
Start-End Page:
48491 - 48492
Page Count:
2
Comment Start Date:
August 14 2012, at 12:00 AM Eastern Standard Time
Comment Due Date:
October 5 2012, at 11:59 PM Eastern Standard Time
Comments
View All
Total:
30
Reengineering LLC - Comment
Posted:
09/05/2012
ID:
FDA-2012-N-0780-0002
Comment Period Closed
Oct 05,2012 11:59 PM ET
Novo Nordisk Inc - Comment
Posted:
10/17/2012
ID:
FDA-2012-N-0780-0004
Comment Period Closed
Oct 05,2012 11:59 PM ET
BioClinica - Comment
Posted:
10/19/2012
ID:
FDA-2012-N-0780-0006
Comment Period Closed
Oct 05,2012 11:59 PM ET
Duke University School of Medicine - Comment
Posted:
10/19/2012
ID:
FDA-2012-N-0780-0007
Comment Period Closed
Oct 05,2012 11:59 PM ET
Astellas Pharma Global Development, Inc. - Comment
Posted:
10/19/2012
ID:
FDA-2012-N-0780-0008
Comment Period Closed
Oct 05,2012 11:59 PM ET
Related Documents
More
Total:
15
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Administrative Detention under the Food and Drug Administration Safety and Innovation Act
Tobacco Product Manufacturing Practice; Establishment of a Public Docket
Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Meeting; Request for Comments; Correction
See FDA-2012-N-0780-0001
Revision of Organization and Conforming Changes to Regulations
Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice; Public Hearing; Request for Comments
Preemption Review
Revised Guidance on Marketed Unapproved Drugs; Availability: Marketed New Drugs Without Approved NDAs or ANDAs
Periodic Reviews of Existing Regulations
Food Safety Modernization Act, Focus on Preventive Controls for Facilities; Notice of Public Meeting
Revision of Organization and Conforming Changes to Regulations
Withdrawal of Certain Proposed Rules and Other Proposed Actions
Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Meeting; Request for Comments
Details Information
Comments
View AllPosted: 09/05/2012 ID: FDA-2012-N-0780-0002
Oct 05,2012 11:59 PM ET
Posted: 10/17/2012 ID: FDA-2012-N-0780-0004
Oct 05,2012 11:59 PM ET
Posted: 10/19/2012 ID: FDA-2012-N-0780-0006
Oct 05,2012 11:59 PM ET
Posted: 10/19/2012 ID: FDA-2012-N-0780-0007
Oct 05,2012 11:59 PM ET
Posted: 10/19/2012 ID: FDA-2012-N-0780-0008
Oct 05,2012 11:59 PM ET
Related Documents
More